Skip to main content
SpringerLink
Log in

Axillary Lymphadenectomy for Melanoma

  • Chapter
  • First Online:
Chassin's Operative Strategy in General Surgery

  • 582 Accesses

Abstract

This chapter describes the performance of classical radical axillary lymphadenectomy. This encompasses level I, II, and III nodes. It is primarily used for melanoma and other cutaneous malignancies metastatic to axillary nodes. Axillary staging for breast cancer is described in Chap. 113.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Further Reading

  • Davis PG, Serpell JW, Kelly JW, Paul E. Axillary lymph node dissection for malignant melanoma. ANZ J Surg. 2011;81:462.

    Article  PubMed  Google Scholar 

  • McNeil C. Endoscopy removal of axillary nodes gains ground abroad, toehold in U.S. J Natl Cancer Inst. 1999;91:582.

    Article  PubMed  CAS  Google Scholar 

  • Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg. 1997;63:97.

    PubMed  CAS  Google Scholar 

  • Namm JP, Chang AE, Cimmino VM, Rees RS, Johnson TM, Sabel MS. Is a level III dissection necessary for a positive sentinel lymph node in melanoma? J Surg Oncol. 2012;105:225.

    Article  PubMed  Google Scholar 

  • Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ration provides prognostic information in addition to American Joint Committee on Cancer N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg. 2011;253:109.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 200 Hawkins Drive, 4622 JCP, Iowa City, IA, 52242, USA

    Carol E. H. Scott-Conner MD, PhD

  2. Department of Surgery, New York University School of Medicine, New York, NY, USA

    Jameson L. Chassin MD

Authors
  1. Carol E. H. Scott-Conner MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jameson L. Chassin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol E. H. Scott-Conner MD, PhD .

Editor information

Editors and Affiliations

  1. College of Medicine Department of Surgery, University of Iowa Roy J and Lucille A Carver, Iowa City, Iowa, USA

    Carol E.H. Scott-Conner

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Scott-Conner, C.E.H., Chassin, J.L. (2014). Axillary Lymphadenectomy for Melanoma. In: Scott-Conner, C. (eds) Chassin's Operative Strategy in General Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1393-6_117

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1393-6_117

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1392-9

  • Online ISBN: 978-1-4614-1393-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation